Safety and Efficacy Study of PEG-uricase in the Treatment of Hyperuricemic Patients With Symptomatic Gout

PHASE3CompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

December 31, 2007

Conditions
Gout
Interventions
OTHER

placebo

placebo by intravenous infusion every 2 weeks

BIOLOGICAL

pegloticase

8 mg pegloticase by intravenous infusion

Trial Locations (56)

16635

Altoona Center for Clinical Research, Duncansville

19154

Mid Atlantic Research Assoc., Philadelphia

20422

Veterans Affairs Medical Center, Washington D.C.

20902

The Center for Rheumatology and Bone Research, Wheaton

21239

Peter A. Holt, M.D., Baltimore

21740

Malamet & Klein, MD, PA, Hagerstown

27302

Duke University Medical Center, Durham

27834

Brody School of Medicine, East Carolina University, Greenville

Physicians East, P.A., Greenville

28401

Carolina Atthritis Associates, Wilmington

29407

Rheumatology Associates, Charleston

29601

Piedmont Arthritis, PA, Greenville

32073

Arthritis & Osteoporosis Treatment Center, PA, Orange Park

32608

Malcom Randall VA Medical Center, Gainesville

33021

Horizon Institute for Clinical Research, Hollywood

33180

Arthritis & Rheumatic Disease Specialties, Aventura

33703

St. Petersburg Arthritis Center, St. Petersburg

34474

Ocala Rheumatology Research Center, Ocala

35294

UAB Arthritis Clinical Intervention Program, Birmingham

42101

Graves Gilbert Clinic, Bowling Green

43210

The Ohio State University, Columbus

44143

David R. Mandel, MD, Inc., Mayfield Village

44195

The Cleveland Clinic Foundation, Cleveland

45242

New Horizons Clinical Research, Cincinnati

45402

STAT Research, Inc., Dayton

48116

Michigan Arthritis Research Center, Brighton

48910

Justus J. Fiechtner, MD, PC, Lansing

53217

Rheumatic Disease Center, Glendale

55905

Mayo Clinic, Rochester

56377

CentraCare Clinic, Saint Cloud

60637

The University of Chicago, Chicago

72401

NEA Clinic, Jonesboro

73139

Health Research of Oklahoma, Oklahoma City

76708

Arthritis & Osteoporosis Clinic Research Center of Central Texas, Waco

78232

Arthritis & Osteoporosis Center of South Texas, San Antonio

79106

AAMR Research Clinic, Amarillo

80910

Arthritis Associates & Osteoporosis Center of Colorado Springs, Colorado Springs

83401

Institute of Arthritis Research, Idaho Falls

83702

Idaho Arthritis & Osteoporosis Center, Boise

85724

University of Arizona Arthritis Center, Tucson

90601

E. Robert Harris Medical Corporation, Whittier

90606

Agilence Arthritis & Osteoporosis Medical Center, Whittier

93454

Pacific Arthritis Center Medical Group, Santa Maria

94118

Kaiser Permanente Medical Center, Clinical Trials Unit, San Francisco

97224

Portland Medical Associates, Portland

99204

Arthritis Northwest, PLLC, Spokane

92037-0943

UCSD Rheumatology Division, La Jolla

01605

Fallon Clinic, Inc, Worcester

07666

Rheumatology Associates of North Jersey, Teaneck

10029-6574

Mount Sinai Medical Center, New York

R3A 1M3

Manitoba Clinic, Winnipeg

N6A 4V2

St. Joseph's Health Care, London

Unknown

Clinica para el Diagnostico y Tratamiento de las Enfermedades Rheumaticas, México

Hospital General de mexico, México

Antiguo Hospital Civil de Guadalajara, Guadalajara

Hospital Civil de Guadalajara, Guadalajara

Sponsors
All Listed Sponsors
lead

Savient Pharmaceuticals

INDUSTRY